Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arachidonic Acid and Quinacrine

Research Papers that Mention the Interaction

Conversely, the phospholipase A2 inhibitor quinacrine (100 μM) blocked the release of arachidonic acid and PGE2 without affecting the NKA-stimulated formation of IP3.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  1998  |  View Paper
Quinacrine , which inhibits the liberation of arachidonic acid from phospholipids, also blocks the formation of lysophosphatidylinositol.
The Journal of biological chemistry  •  1982  |  View Paper
The liberation of arachidonic acid from membrane‐bound phospholipids, induced by the enzyme phospholipase A2, may be inhibited by mepacrine and the steroidal anti‐inflammatory agents.
Acta obstetricia et gynecologica Scandinavica. Supplement  •  1979  |  View Paper
Supplementation with arachidonic acid (AA) sustained caspase-3 activation induced by QU.
Archives of pharmacal research  •  2001  |  View Paper
In the presence of either quinacrine , an inhibitor of PLA2 pathway activation, or neomycin, which binds to PI mono- and biphosphate thus blocking their degradation by phospholipases, AA and PGE2 secretion were reduced in a dose-dependent manner.
Arthritis and rheumatism  •  1993  |  View Paper
The production of arachidonic acid is not inhibited by neomycin, a PI-cycle inhibitor, but is completely abolished by mepacrine , an inhibitor of both phospholipase A2 and C. At low concentration of fluoroaluminate (10 mM NaF) phospholipase A2 but not phospholipase C is activated.
Biochimica et biophysica acta  •  1992  |  View Paper
The aggregation of human platelets induced by Et3PbCl was inhibited by three different drugs: acetylsalicylic acid, forskolin and quinacrine; but only quinacrine could prevent the liberation of arachidonic acid and the appearance of its metabolites.
European journal of biochemistry  •  1987  |  View Paper
Mepacrine , at this concentration, also blocked thrombin-induced phosphorylation of platelet myosin light chain and a 47 kDa protein, thrombin-induced secretion and thrombin-induced release of arachidonic acid from platelet phospholipids.
Biochimica et biophysica acta  •  1985  |  View Paper
Finally, isobutylmethylxanthine and quinacrine , inhibitors of phosphatidylinositol turnover, inhibit both arachidonic acid generation and phagocytosis, indicating a function for this pathway during this process.
The Biochemical journal  •  1982  |  View Paper
This same amount of PI is converted to PA even in the presence of 1 mM quinacrine , which completely inhibits the release of arachidonic acid from phospholipids and which reduces by two-thirds the loss of labeled PI.
The Journal of biological chemistry  •  1981  |  View Paper
Show More